Anti-vaccination blog revives debunked HPV story

| December 20, 2016

article image
The post on an anti-vaccination website was damning.The headline "Bill Gates uses 30,000 Indian girls as guinea pigs to test cancer vaccine," appeared on the Organic & Healthy blog in October and is still being shared. The article described a 2009 human papillomavirus vaccination demonstration project in India. In the span of about a year, thousands of girls between the ages of 10 and 14 received one of two vaccines to prevent genital warts that are linked to cancer later in life.

Spotlight

MS PHARMA

MS Pharma is a leading pharmaceutical, healthcare solutions provider and partner of choice company that is manufacturing and marketing generic medicines through its leading affiliates in several strategic markets across the MENA region. The company is headquartered in Jordan, It unifies EL KENDI in Algeria, UPM in Jordan, MS Pharma Injectables and MS Pharma Turkey. MS Pharma is committed to offer high quality generic medicines with added value by basing its production on new technologies and state-of-the-art facilities implemented all around the MENA region.

OTHER ARTICLES

Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks?

Article | April 1, 2020

Pharmaceutical stocks have been somewhat of a safe haven for investors as the coronavirus outbreak spread from China to the rest of the world. But as the pandemic deepened, now resulting in more than 782,000 cases worldwide, even these "safer" companies are beginning to feel the effects. The U.S. is now the coronavirus epicenter, with the most cases -- more than 161,000 as of today. Initial concerns for drugmakers had to do with the supply of active pharmaceutical ingredients, which often come from China. The worry was that pharmaceutical companies wouldn't be able to produce enough of their drugs for patients.

Read More

How AI and Big Data Will Disrupt Pharma’s Regulatory Compliance Standards

Article | March 4, 2020

The industry as we know it is changing. Pharmaceutical and life sciences companies across the globe are experiencing more pressure than ever to keep up with increased regulatory standards while moving at a pace that requires them to innovate in order to remain competitive. With more real-time automation and the steady increase in AI and Big Data sweeping the landscape, what used to be a slow-to-change and risk-averse industry is now expected to see a significant shift towards newer technology that focus on heightened regulatory standards. Here’s how your company can get ahead of what industry experts are calling, Pharma

Read More

Roche Prepares to Launch COVID-19 Antibody Test System

Article | April 17, 2020

Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease. This morning, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the SARS-CoV-2, the virus that causes COVID-19. Roche is eying May for the launch of the test in Europe and is in talks with the U.S Food and Drug Administration for emergency approval of the system. Antibody testing is central to help identify people who have been infected by the virus, especially those who may have been infected but did not display symptoms, the company said. Roche noted that as more information becomes available about immunity levels to COVID-19, society can return to a sense of normal much more quickly. Roche’s test will join a number of other antibody tests that have recently come on the market. Earlier this month the U.S. Food and Drug Administration approved the first blood test for COVID-19 antibodies.

Read More

Merck’s Patient-Centric Clinical Trial Recruiting

Article | March 4, 2020

Everyone in pharma knows that product success depends on the results of clinical trials — but we don’t usually hear from the people who are involved in running them. Recently, four Clinical Research Managers (CRM) from Merck (known as MSD outside the United States and Canada) discussed how Merck is overcoming the barriers to clinical trial recruitment by adopting a patient-centric process — a model that affects their trials top to bottom, from design through implementation. Each of the panel members manages clinical trials, serving as the main point of interaction with the Clinical Research Associates (CRAs) on research requirements, goals, and resources, including recruiting and retention.

Read More

Spotlight

MS PHARMA

MS Pharma is a leading pharmaceutical, healthcare solutions provider and partner of choice company that is manufacturing and marketing generic medicines through its leading affiliates in several strategic markets across the MENA region. The company is headquartered in Jordan, It unifies EL KENDI in Algeria, UPM in Jordan, MS Pharma Injectables and MS Pharma Turkey. MS Pharma is committed to offer high quality generic medicines with added value by basing its production on new technologies and state-of-the-art facilities implemented all around the MENA region.

Events